Greatbatch Buys Micro Power - Analyst Blog
December 15 2011 - 7:45AM
Zacks
Greatbatch’s (GB)
Electrochem division, which offers high performance commercial
batteries, has inked a definitive pact to take over Oregon-based
battery supplier Micro Power Electronics for roughly $60 million in
cash. The deal also calls for assumption of debt and specific
acquisition-related payments and expenses.
The transaction is expected to
close by end-2011. Greatbatch plans to fund the acquisition with
available cash and its existing revolving credit facility.
Micro Power supplies custom battery
solutions to the portable medical, military and automatic
identification and data collection markets. Its coveted product
portfolio complements Electrochem’s offerings for the portable
medical, energy, military and environmental industries.
The acquisition is expected to
diversify Electrochem’s revenues by broadening its foothold in the
portable medical battery market and stimulating growth in other key
areas. Electrochem plans to retain Micro Power’s Oregon facility
which employs roughly 200 people.
Micro Power is expected to generate
roughly $70 million in sales in 2011. The acquisition is expected
to be neutral to Greatbatch’s earnings (barring one-time
acquisition related charges) in 2011 and 2012 and accretive
thereafter.
Greatbatch is a leading producer
and supplier of batteries, capacitors and components used in
implantable medical devices. The company’s top customers include
Boston Scientific (BSX), Johnson &
Johnson (JNJ), Medtronic (MDT) and
St. Jude (STJ).
Greatbatch’s smaller Electrochem
division makes high performance batteries for use in oil and gas
exploration, oceanographic equipment, seismic surveying equipment
and aerospace. The division accounted for roughly 14% of the
company’s sales in 2010.
Greatbatch has been acquiring
complementary businesses over the last few years to boost sales.
The company’s pipeline is healthy with a number of products
currently under development that are expected to support growth in
the long run. Moreover, Greatbatch continues to invest in
developing medical devices for its major OEM clients.
We feel that operating results will
be supported by strength at the company’s orthopedic business and
strategic investments. Moreover, synergies from cost-cutting and
restructuring initiatives are expected to support margin expansion.
Our Outperform recommendation on the stock is backed by a Zacks #2
Rank, which translates into a short-term “Buy” recommendation.
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
GREATBATCH INC (GB): Free Stock Analysis Report
JOHNSON & JOHNS (JNJ): Free Stock Analysis Report
MEDTRONIC (MDT): Free Stock Analysis Report
ST JUDE MEDICAL (STJ): Free Stock Analysis Report
Zacks Investment Research
SJM (NYSE:STJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Jul 2023 to Jul 2024